Quick Links

Journal of Pharmaceutical Innovation Advertising Production Requirements

Advertising Production Requirements
JPI is printed with perfect binding. Ad materials should be submitted as high resolution Adobe Acrobat® PDF files with fonts and images embedded sent via e-mail to Dave Hall at dhall@ISPE.org. The publisher cannot change or correct a PDF file, therefore, the advertiser will be asked to send a new, corrected file if required. The advertiser will be charged for any prepress work required if files are incorrect or incomplete. Additional charges that may be incurred include scans, typesetting, repairing files, color correction, and image editing. The publisher will archive files for up to 18 months. If the advertisement has not been used in a publication in the past 18 months the files may be deleted.

Publisher
The International Society for Pharmaceutical Engineering, Inc.
ISPE Headquarter, 3109 W. Dr. Martin Luther King Jr. Blvd., Suite 250, Tampa, Florida, 33607 USA
Telephone: +1-813-960-2105, Fax: +1-813-264-2816

Advertising Agency Commissions
Fifteen percent (15%) of gross paid to accredited advertising agencies on all space ONLY if the total amount due is paid in full within 45 days of publication issue date. Commissions do not apply to any production charges.

Billing
Invoices are rendered at publication issue date; due upon receipt. Both advertiser and specified advertising agency are held fully responsible for all authorized advertising insertions. All past-due invoices will be re-invoiced directly to the advertiser, who will be held fully responsible for payment. All accounts past 90 days will be assessed a monthly service charge of 1.5 percent of the unpaid balance.

Publisher’s Rights and Contract Conditions

  1. The publisher reserves the right to reject any advertisement that, in the opinion of the publisher, does not meet the standards of the publication.
  2. The publisher can assume no liability if for any reason it becomes necessary to omit an advertisement from a particular issue.
  3. The publisher’s liability for any error will not exceed the cost of the space occupied by the error.
  4. In submitting an advertising insertion order, advertisers agree to pay all costs of collection including reasonable attorney fees and court costs in the event of default of payment.
  5. All advertisements are published on the representation that the advertiser or the advertising agency is properly authorized to publish the entire contents and all subject matter. The advertiser or advertising agency indemnifies and holds the publisher harmless from any claims or suits based upon the contents and subject matter of any advertisements.
  6. Insertion instructions shall be supplied for every advertisement and shall clearly state the following: name of publication, name of advertiser, date to be inserted, size of advertisement, identification of advertisement (proof of ad to be furnished if possible), plus any special instructions such as bleed, color, etc.
  7. No conditions, printed or otherwise, appearing on the space order, billing instructions or copy instructions which conflict with the publisher’s stated policies will be binding on the publisher.
  8. Space orders, wherever possible, should specify a definite schedule of insertions, issues, and sizes of space.
  9. The publisher reserves the right to give better position than specified in the order, at no increase in rate.
  10. The publisher assumes no liability for errors in the advertiser’s index.
  11. The publisher is not liable for delays in delivery and/or nondelivery in the event of an Act of God, action by any governmental or quasi-governmental entity, fire, flood, insurrection, riot, explosion, embargo, strikes whether legal or illegal, labor or material shortage, transportation interruption of any kind, work slowdown, or any condition beyond the control of the publisher affecting production or delivery in any manner.
  12. Requests for specified position at Rate of Page (ROP) rates are given consideration, but no guarantee is made unless the position premium has been provided for in the contract.

For more information, contact:

  • Dave Hall, ISPE Director of International Sales
    3109 W. Dr. Martin Luther King, Jr. Blvd., Suite 250, Tampa, FL 33607 USA.
    Tel: 1-813-960-2105
    Fax: 1-813-264-2816
  • Karen Newhouse,  Account Executive
    Tel: 1-813-960-2105 x254
    Fax: 1-813-264-2816

In Europe, contact:

  • Christine Sainvil, European Sales Manager
    Avenue de Tervueren, 300, B-1150 Brussels, Belgium
    Tel: 32-2-743-4422
    Fax: 32-2-743-1550

Page last updated: 15 August 2008

Copyright © International Society for Pharmaceutical Engineering   |   Privacy Policy   |   Terms of Use